Skip to main content

Table 1 Patient and target information

From: Dose delivery reproducibility for PBS proton treatment of breast cancer patients with and without mask immobilization

 

With mask

No mask

Age

  

Median (range)

67 (36, 85)

65 (32, 83)

Number of patients

69

25

Breast

43

9

CW

26

16

Laterality

  

Left

38

20

Right

25

4

Bilateral

6

1

Nodal regions treated

  

Axilla

57

20

SCV

52

20

IMN

51

19

Breast/CW Rx (cGyRBE)

  

5 × (500 or 520)

4

8

15 × 267

36

14

25 × (180 or 200)

21

2

Other

8

1

SIB

34

6

CTV Volume (cc)

  

Median (range)

  

Boost

38.3 (4.2, 463.0)

92.6 (5.3, 749.9)

Breast/CW

685.1 (163.6, 2599.5)

671.1 (142.3, 1808.7)

Axilla

116.5 (40.6, 343.4)

136.7 (45.0, 289.1)

SCV

23.4 (10.3, 69.8)

27.6 (10.3, 54.7)

IMN

6.0 (1.0, 27.1)

6.0 (1.5, 15.3)

  1. CW, chest wall; SCV, supraclavicular nodes; IMN, internal mammary nodes; Rx, prescription; GyRBE, Relative-Biological-Effectiveness dose in Gray; SIB, simultaneous integrated boost; CTV, clinical target volume